Michael Korrer

发表

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines

M. Welters, Pornpimol Charoentong, S. Santegoets, 2018, Cell.

Possible Role of Arginase-1 in Concomitant Tumor Immunity

J. Routes, Michael Korrer, 2014, PloS one.

Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D

J. Routes, Michael Korrer, 2015, Results in immunology.

Paradoxical decrease in the capture and lymph node delivery of cancer vaccine antigen induced by a TLR4 agonist as visualized by dual-mode imaging.

J. Bulte, H. Levitsky, Deepak K. Kadayakkara, 2015, Cancer research.

Efferocytosis drives myeloid NLRP3 dependent inflammasome signaling secretion of IL-1β to promote tumor growth

Yaomin Xu, Yu Wang, Cara Lang, 2022, Frontiers in Immunology.

Induction of tumor regression by intratumoral STING agonists combined with anti–programmed death‐L1 blocking antibody in a preclinical squamous cell carcinoma model

C. Allen, Juan Fu, S. Gadkaree, 2017, Head & neck.

MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses

V. Quaranta, Christian T. Meyer, John T. Wilson, 2022, Frontiers in Immunology.

Immunostimulatory cancer-associated fibroblast subpopulations can predict immunotherapy response in head and neck cancer.

X. Liu, A. Califano, C. Drake, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Caspase-1 from Human Myeloid-Derived Suppressor Cells Can Promote T Cell–Independent Tumor Proliferation

David L. Masica, D. Pardoll, D. Masica, 2018, Cancer Immunology Research.

903 Human cancer-associated fibroblast subsets can predict immune checkpoint response in head and neck cancer patients

A. Califano, C. Drake, Yaomin Xu, 2021, Journal for ImmunoTherapy of Cancer.

Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy

Nirbhay N. Yadav, A. Pathak, A. Bar‐Shir, 2018, Magnetic resonance in medicine.

Phenotypical and functional analysis of natural killer cells from primary human head and neck squamous cell carcinomas

Michael Korrer, Young J Kim, 2019, The Journal of Immunology.